Anticoagulation and antiplatelet management in gastrointestinal endoscopy: A review of current evidence

Table 35 Polypectomy

Ref.	Year	Country	Study design	n	Polyp morphology	Procedure	Medication	Relative risk
Singh et al[28]	2010	United States	Retrospective	77	Size: < 5 mm to ≥ 10 mm	Polypectomy	DAPT (continued)	Incidence of delayed PPB 5.2%
Feagins et al[30]	2011	United States	Retrospective	118	Size: < 20 mm and > 20 mm	Polypectomy	DAPT (continued)	Incidence of PPB 0.85%
Kishida et al[41]	2019	Japan	Retrospective	6382	Size: < 10 mm or ≥ 10 mm	Polypectomy	DAPT either: (1) Ceased 7 d before (before 2012); (2) Bridged with aspirin monotherapy (after 2012)	Incidence of PPB 1.8%
Watanabe et al[109]	2020	Japan	Retrospective	50	Size: < 10 mm or ≥ 10 mm	Polypectomy	DAPT (various timing of agent continuation or switching strategies)	Incidence of PPB 6%

DAPT: Dual antiplatelet therapy; PPB: Post-procedural bleeding.